Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» Regeneron
Regeneron
Sanofi, Regeneron team with Broadway actor for digital severe asthma program
Medical Marketing and Media
Wed, 10/19/22 - 10:54 pm
asthma
severe asthma
Sanofi
Regeneron
pharma marketing
FDA Review: Phanes, Pfizer, GSK and More
BioSpace
Fri, 10/14/22 - 10:38 am
FDA
Phanes
Pfizer
GSK
Regeneron
Eagle Pharmaceuticals
Galactin Therapeutics
BridgeBio
Gilead Sciences
Covis Pharma
scPharmaceuticals
XACT Robotics
BioMind Labs
Regeneron secures priority review for Eylea's use in infant retinopathy
Fierce Pharma
Wed, 10/12/22 - 11:40 pm
Eylea
Regeneron
retinopathy of prematurity
FDA
priority review
Dupixent Shows Promise as First Treatment for Childhood EoE
BioSpace
Wed, 10/12/22 - 10:33 am
Dupixent
Sanofi
Regeneron
pediatric
clinical trials
eosinophilic esophagitis
The gloom deepens for biopharma stocks
EP Vantage
Mon, 10/10/22 - 06:54 pm
biopharma stocks
AbbVie
Alnylam
AstraZeneca
Biogen
CRISPR Therapeutics
Daiichi Sankyo
Eisai
Eli Lilly
GSK
Intellia Therapeutics
Regeneron
Roche
Sanofi
Sarepta Therapeutics
FDA approves Sanofi and Regeneron’s Dupixent to treat prurigo nodularis
Pharmaceutical Business Review
Thu, 09/29/22 - 10:05 am
Sanofi
Regeneron
Dupixent
prurigo nodularis
FDA
Biden admin says Supreme Court should reject Amgen's petition to take up Repatha patent case
Fierce Pharma
Thu, 09/22/22 - 11:14 pm
Amgen
patents
Supreme Court
Repatha
Sanofi
Regeneron
Intellia's gene editing therapies both post early successes as evidence grows for CRISPR potential
Fierce Biotech
Fri, 09/16/22 - 10:53 am
Intellia Therapeutics
gene editing
NTLA-2001
ATTR amyloidosis
clinical trials
Regeneron
ESMO 2022 movers – KRAS backfires
EP Vantage
Thu, 09/15/22 - 10:12 am
ESMO
KRAS inhibitors
Relay Therapeutics
Regeneron
Amgen
Deciphera
Clovis Oncology
Ayala Pharmaceuticals
Springworks
Mirati Therapeutics
Regeneron Highlights Plug-and-Play Oncology Strategy at ESMO
BioSpace
Mon, 09/12/22 - 11:32 pm
ESMO
Regeneron
Libtayo
Bayer, Regeneron's eye drug shown to work at higher dose, longer intervals
Yahoo/Reuters
Thu, 09/8/22 - 04:33 pm
Bayer
Regeneron
Eylea
diabetic macular edema
wet age-related macular degeneration
Alnylam clears phase 2 test for Regeneron-partnered nephropathy med, as it looks to play catch-up against Calliditas
Fierce Biotech
Tue, 08/30/22 - 11:48 am
Alnylam
Regeneron
Calliditas
immunoglobin A nephropathy
clinical trials
Alnylam Reports Positive Results from Phase 2 Study of Investigational Cemdisiran for the Treatment of IgA Nephropathy
Businesswire
Mon, 08/29/22 - 10:26 am
Alnylam Pharmaceuticals
clinical trials
cemdisiran
Regeneron
IgAN
immunoglobultin A nephropathy
RNAi
Drug makers leave the pain behind
EP Vantage
Fri, 08/26/22 - 10:26 am
painkillers
Acadia
Eli Lilly
Ampio Pharmaceuticals
Aptinyx
Eliem Therapeutics
Vertanical
Teva Pharamceutical
Regeneron
Vivozon
Vertex Pharmaceuticals
Biogen
Kodiak matches Regeneron’s Eylea in macular edema phase 3, lighting Beacon of hope after flop
Fierce Biotech
Tue, 08/9/22 - 06:34 am
Kodiak Sciences
Regeneron
Bayer
Eylea
macular edema
clinical trials
tarcocimab
Regeneron's Dupixent and Eylea Offset Drop in COVID-19 Antibody Sales
BioSpace
Wed, 08/3/22 - 09:19 pm
Regeneron
earnings
COVID-19
Eylea
Dupixent
Look out, Regeneron. As the threat from Roche's Vabysmo grows, one team of analysts slashes its Eylea sales estimate
Fierce Pharma
Mon, 07/25/22 - 10:00 pm
Regeneron
Eylea
Roche
Vabysmo
Regeneron, Sanofi Look to Extend Dupixent into Young Kids with Eosinophilic Esophagitis
BioSpace
Thu, 07/14/22 - 11:49 am
Regeneron
Sanofi
Dupixent
pediatric
eosinophilic esophagitis
Regeneron completes acquisition of Sanofi’s stake in Libtayo
Pharmaceutical Business Review
Mon, 07/4/22 - 11:58 pm
Regeneron
Sanofi
Libtayo
cancer
Sanofi's Top-Selling Drug Just Snagged Another Approval From the FDA
Motley Fool
Mon, 06/27/22 - 10:12 am
Sanofi
Regeneron
FDA
Dupixent
eosinophilic esophagitis
Pages
« first
‹ previous
…
2
3
4
5
6
7
8
9
10
…
next ›
last »